enGene Therapeutics Inc ENGNNasdaq
1.75USDClose on 08/10
At a glance
enGene Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved -75.9% since its first surge signal on 2026-04-30, when the past-year gain stood at +81.7%.
- Since surge signal
- -75.9%
- First surge signal
- 2026-04-30
- Price at signal
- 7.27
- Past-year gain (at signal)
- +81.7%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.